Christopher Gibson, Director: Recursion Pharmaceuticals RXRX Planned sale · Filed 06/18

Trade details

Type: Planned sale notice
Stock: Recursion Pharmaceuticals RXRX
Person: Christopher GibsonDirector
Planned sale date: 26/06/18
Filed: 26/06/18

More to sell after $801.2K in 3 months

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/19~07/18

Christopher Gibson's recent trades

Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$262K
77,290 sh
$262K
Filed 08/21
Traded 08/21
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$255K
75,000 sh
$255K
Filed 08/20
Traded 08/20
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$327.5K
100,000 sh
$327.5K
Filed 08/19
Traded 08/19
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$80.4K
26,806 sh
$80.4K
Filed 08/18
Traded 08/18
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$331K
100,000 sh
$331K
Filed 08/13
Traded 08/13

Christopher Gibson, Director — plans to sell 300,440 sh of Recursion Pharmaceuticals RXRX · $962.3K · around 06/18 | Whalegun